Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Slobodan Rendic. (2002) Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metabolism Reviews 34:1-2, pages 83-448.
Read now
Read now
Lars W. Wormhoudt, Jan N. M. Commandeur & Nico P. E. Vermeulen. (1999) Genetic Polymorphisms of Human N-Acetyltransferase, Cytochrome P450, Glutathione-S-Transferase, and Epoxide Hydrolase Enzymes: Relevance to Xenobiotic Metabolism and Toxicity. Critical Reviews in Toxicology 29:1, pages 59-124.
Read now
Read now
DEBRA J. COSTA1, VALERIE SLOTT1, BLANKA BINKOVA, STEVEN R. MYERS & JOELLEN LEWTAS. (1998) Influence of GSTM1 and NAT2 genotypes on the relationship between personal exposure to PAH and biomarkers of internal dose. Biomarkers 3:6, pages 411-424.
Read now
Read now
G. T. TUCKER, A. ROSTAMI-HODJEGAN & P. R. JACKSON. (1998) Determination of drug-metabolizing enzyme activity in vivo : pharmacokinetic and statistical issues. Xenobiotica 28:12, pages 1255-1273.
Read now
Read now
Slobodan Rendic & Frederick J. Di Carlo. (1997) Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and Inhibitors. Drug Metabolism Reviews 29:1-2, pages 413-580.
Read now
Read now
S. Madden, V. Spaldin, R. N. Hayes, T. F. Woolf, W. F. Pool & B. K. Park. (1995) Species variation in the bioactivation of tacrine by hepatic microsomes. Xenobiotica 25:1, pages 103-116.
Read now
Read now
Articles from other publishers (49)
Mark S. Johnson. 2003. Patty's Toxicology. Patty's Toxicology
1
107
.
Julia Kastner, Rydhwana Hossain & Charles S. White. (2020) Epidemiology of Lung Cancer. Seminars in Roentgenology 55:1, pages 23-40.
Crossref
Crossref
Sofia Paraskevopoulou, Alice B. Dennis, Guntram Weithoff, Stefanie Hartmann & Ralph Tiedemann. (2019) Within species expressed genetic variability and gene expression response to different temperatures in the rotifer Brachionus calyciflorus sensu stricto. PLOS ONE 14:9, pages e0223134.
Crossref
Crossref
A.P. Sanders, R.O. Wright, J.D. Groopman & J.-S. Wang. 2018. Comprehensive Toxicology. Comprehensive Toxicology
683
708
.
Kimiko Tomioka, Keigo Saeki, Kenji Obayashi & Norio Kurumatani. (2016) Risk of Lung Cancer in Workers Exposed to Benzidine and/or Beta-Naphthylamine: A Systematic Review and Meta-Analysis. Journal of Epidemiology 26:9, pages 447-458.
Crossref
Crossref
Bo-Young Lee, Hui-Su Kim, Beom-Soon Choi, Dae-Sik Hwang, Ah Young Choi, Jeonghoon Han, Eun-Ji Won, Ik-Young Choi, Seung-Hwi Lee, Ae-Son Om, Heum Gi Park & Jae-Seong Lee. (2015) RNA-seq based whole transcriptome analysis of the cyclopoid copepod Paracyclopina nana focusing on xenobiotics metabolism. Comparative Biochemistry and Physiology Part D: Genomics and Proteomics 15, pages 12-19.
Crossref
Crossref
Eula Bingham & William J. McGowan. 2001. Patty's Toxicology. Patty's Toxicology
1
92
.
Karin E. Broberg, Margareta Warholm, Håkan Tinnerberg, Anna Axmon, Bo A. Jönsson, Carl Johan Sennbro, Margareta Littorin & Agneta Rannug. (2010) The GSTP1 Ile105 Val polymorphism modifies the metabolism of toluene di-isocyanate. Pharmacogenetics and Genomics 20:2, pages 104-111.
Crossref
Crossref
J.D. Groopman & J.-S. Wang. 2010. Comprehensive Toxicology. Comprehensive Toxicology
267
295
.
J.M. Links & J.D. Groopman. 2010. Comprehensive Toxicology. Comprehensive Toxicology
225
243
.
John A. Timbrell & Timothy C. Marrs. 2009. General and Applied Toxicology. General and Applied Toxicology.
P. Hodek, J. Křížková, K. Burdová, M. Šulc, R. Kizek, J. Hudeček & M. Stiborová. (2009) Chemopreventive compounds—View from the other side. Chemico-Biological Interactions 180:1, pages 1-9.
Crossref
Crossref
John Timbrell. 2008. Principles of Biochemical Toxicology, Fourth Edition. Principles of Biochemical Toxicology, Fourth Edition
129
191
.
S. Yu. Garmonov, N. S. Shilova, A. V. Yakoleva & R. A. Yusupov. (2008) Indirect determination of N-acetyltransferase activity using ammonium metavanadate for evaluating isoniazide excretion with human urine. Pharmaceutical Chemistry Journal 42:8.
Crossref
Crossref
Margareta Littorin, Saimei Hou, Karin Broberg, Jonas Björk, Susanne Fält, Galbani Abdoulaye, Malgorzata Kalemba, Charlotta Ryk & Staffan Skerfving. (2007) Influence of polymorphic metabolic enzymes on biotransformation and effects of diphenylmethane diisocyanate. International Archives of Occupational and Environmental Health 81:4, pages 429-441.
Crossref
Crossref
Peter Gresner, Jolanta Gromadzinska & Wojciech Wasowicz. (2007) Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer. Lung Cancer 57:1, pages 1-25.
Crossref
Crossref
E E Thompson, H Kuttab-Boulos, L Yang, B A Roe & A Di Rienzo. (2005) Sequence diversity and haplotype structure at the human CYP3A cluster. The Pharmacogenomics Journal 6:2, pages 105-114.
Crossref
Crossref
A Prawan, V Kukongviriyapan, W Tassaneeyakul, C Pairojkul & V Bhudhisawasdi. (2005) Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma. European Journal of Cancer Prevention 14:3, pages 245-250.
Crossref
Crossref
O.N. Mikhailova, L.F. Gulyaeva & M.L. Filipenko. (2005) Gene expression of drug metabolizing enzymes in adult and aged mouse liver: A modulation by immobilization stress. Toxicology 210:2-3, pages 189-196.
Crossref
Crossref
Edward F. Fitzgerald, Syni-An Hwang, George Lambert, Marta Gomez & Alice Tarbell. (2005)
PCB Exposure and
in Vivo
CYP1A2 Activity among Native Americans
. Environmental Health Perspectives 113:3, pages 272-277.
Crossref
Crossref
María Elena Martínez. 2005. Tumor Prevention and Genetics III. Tumor Prevention and Genetics III
177
211
.
Ana Fanlo, Blanca Sinués, Esteban Mayayo, Luisa Bernal, Antonia Soriano, Begoña Martínez‐Jarreta & Enrique Martínez‐Ballarín. (2004) Urinary Mutagenicity, CYP1A2 and NAT2 Activity in Textile Industry Workers. Journal of Occupational Health 46:6, pages 440-447.
Crossref
Crossref
Yoshimitsu Oda. (2004) Analysis of the involvement of human N-acetyltransferase 1 in the genotoxic activation of bladder carcinogenic arylamines using a SOS/umu assay system. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 554:1-2, pages 399-406.
Crossref
Crossref
Y. Tsuneoka, T. P. Dalton, M. L. Miller, C. D. Clay, H. G. Shertzer, G. Talaska, M. Medvedovic & D. W. Nebert. (2003) 4-Aminobiphenyl-Induced Liver and Urinary Bladder DNA Adduct Formation in Cyp1a2(-/-) and Cyp1a2(+/+) Mice. JNCI Journal of the National Cancer Institute 95:16, pages 1227-1237.
Crossref
Crossref
George V. Pickwell, Hsueh Shih & Linda C. Quattrochi. (2003) Interaction of upstream stimulatory factor proteins with an E-box located within the human CYP1A2 5′-flanking gene contributes to basal transcriptional gene activation. Biochemical Pharmacology 65:7, pages 1087-1096.
Crossref
Crossref
Masashi Yabuki, Yutaka Kon-Ya, Masaki Kataoka, Takeshi Shimizudani, Kyoko Akao, Masaki Ito, Hiroshi Kanamaru & Iwao Nakatsuka. (2003) Pharmacokinetics of a novelN-methyl-D-aspartate receptor antagonist (SM-18400): Identification of anN-acetylated metabolite and pre-clinical assessment ofN-acetylation polymorphism. European Journal of Drug Metabolism and Pharmacokinetics 28:1, pages 21-29.
Crossref
Crossref
Dimiter Terziivanov, Kristina Bozhinova, Velislava Dimitrova & Ivanka Atanasova. (2003) Nonparametric Expectation Maximisation (NPEM) Population Pharmacokinetic Analysis of Caffeine Disposition from Sparse Data in Adult Caucasians. Clinical Pharmacokinetics 42:15, pages 1393-1409.
Crossref
Crossref
Tamie Nakajima, Osamu Yamanoshita, Michihiro Kamijima, Reiko Kishi & Gaku Ichihara. (2003) Generalized Skin Reactions in Relation to Trichloroethylene Exposure: A Review from the Viewpoint of Drug‐Metabolizing Enzymes. Journal of Occupational Health 45:1, pages 8-14.
Crossref
Crossref
Marilyn J. Aardema & James T. MacGregor. 2003. Toxicogenomics. Toxicogenomics
171
193
.
John H Weisburger. (2002) Comments on the history and importance of aromatic and heterocyclic amines in public health. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 506-507, pages 9-20.
Crossref
Crossref
Marilyn J. Aardema & James T. MacGregor. (2002) Toxicology and genetic toxicology in the new era of “toxicogenomics”: impact of “-omics” technologies. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 499:1, pages 13-25.
Crossref
Crossref
Wai Nang ChoyJia-Sheng Wang, Jonathan Links & John Groopman. 2001. Genetic Toxicology and Cancer Risk Assessment. Genetic Toxicology and Cancer Risk Assessment
271
298
.
Daniel W. Nebert & Amy L. Roe. (2001) Ethnic and genetic differences in metabolism genes and risk of toxicity and cancer. Science of The Total Environment 274:1-3, pages 93-102.
Crossref
Crossref
Elizabeth K. Weisburger & Vera W. Hudson. 2001. Patty's Toxicology. Patty's Toxicology.
Mary D. Boudreau, David G. BakerH. Wayne Taylor, Steven A. Barker & Jay C. Means. (2016) Suppression of Arylamine Toxicity in the Fischer-344 Rat Following Ingestion of a Complex Mixture. Toxicologic Pathology 29:3, pages 333-343.
Crossref
Crossref
Corlis L Archer, Philo Morse, Richard F Jones, Tomoyuki Shirai, G.P Haas & C.Y Wang. (2000) Carcinogenicity of the N-hydroxy derivative of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, 2-amino-3,8-dimethyl-imidazo[4,5-f]quinoxaline and 3,2?-dimethyl-4-aminobiphenyl in the rat. Cancer Letters 155:1, pages 55-60.
Crossref
Crossref
Dong‐Shen Ou‐Yang, Song‐Lin Huang, Wei Wang, Hong‐Guang Xie, Zhen‐Hua Xu, Yan Shu & Hong‐Hao Zhou. (2002) Phenotypic polymorphism and gender‐related differences of CYP1A2 activity in a Chinese population. British Journal of Clinical Pharmacology 49:2, pages 145-151.
Crossref
Crossref
Krishna R Iyer & Michael W Sinz. (1999) Characterization of Phase I and Phase II hepatic drug metabolism activities in a panel of human liver preparations. Chemico-Biological Interactions 118:2, pages 151-169.
Crossref
Crossref
William Pool. 1999. Handbook of Drug Metabolism. Handbook of Drug Metabolism
577
587
.
Eino Hietanen. 1999. Advances in Nutrition and Cancer 2. Advances in Nutrition and Cancer 2
241
251
.
Henry C. Pitot. (2016) The Progression of Neoplasia, Cell Replication, and Electromagnetic Fields. International Journal of Toxicology 17:3_suppl, pages 59-108.
Crossref
Crossref
Yo Kawakubo & Muneo Ohkido. (1998) Epidermal N-acetylation of p-aminobenzoyl glutamic acid: difference in response to ultraviolet B irradiation. Journal of Dermatological Science 16:2, pages 99-103.
Crossref
Crossref
Maurizio Taningher, Davide Malacarne, Tommaso Mancuso, Marco Peluso, Maria Pia Pescarolo & Silvio Parodi. (1997) Methods for predicting carcinogenic hazards: new opportunities coming from recent developments in molecular oncology and SAR studies. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 391:1-2, pages 3-32.
Crossref
Crossref
Stewart MacLeod, Rashmi Sinha, Fred F Kadlubar & Nicholas P Lang. (1997) Polymorphisms of CYP1A1 and GSTM1 influence the in vivo function of CYP1A2. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 376:1-2, pages 135-142.
Crossref
Crossref
F. Takakubo, M. Yamamoto, N. Ogawa, Y. Yamashita, Y. Mizuno & I. Kondo. (1996) Genetic association between cytochrome P450IA1 gene and susceptibility to Parkinson's disease. Journal of Neural Transmission 103:7, pages 843-849.
Crossref
Crossref
R J Albertini, J A Nicklas & J P O'Neill. (1996) Future research directions for evaluating human genetic and cancer risk from environmental exposures.. Environmental Health Perspectives 104:suppl 3, pages 503-510.
Crossref
Crossref
T. F. Woolf, W. P. Pool, R. M. Walker & D. K. Monteith. 1996. Drug-Induced Hepatotoxicity. Drug-Induced Hepatotoxicity
395
410
.
Fred F Kadlubar & Alaa F. Badawi. (1995) Genetic susceptibility and carcinogen-DNA adduct formation in human urinary bladder carcinogenesis. Toxicology Letters 82-83, pages 627-632.
Crossref
Crossref
C.A.D. Smith, G. Smith & C.R. Wolf. (1994) Genetic polymorphisms in xenobiotic metabolism. European Journal of Cancer 30:13, pages 1921-1935.
Crossref
Crossref